(2R)-2-methylchromane-2-carboxylic acids: discovery of selective PPARalpha agonists as hypolipidemic agents. 2005

Hiroo Koyama, and Julia K Boueres, and Daniel J Miller, and Joel P Berger, and Karen L MacNaul, and Pei-ran Wang, and Marc C Ippolito, and Samuel D Wright, and Arun K Agrawal, and David E Moller, and Soumya P Sahoo
Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA. hiroo_koyama@merck.com

A SAR study was conducted on chromane-2-carboxylic acid toward selective PPARalpha agonisim. As a result, highly potent, and selective PPARalpha agonists were discovered. The optimized compound 43 exhibited robust lowering of total cholesterol levels in hamster and dog animal models.

UI MeSH Term Description Entries
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D008297 Male Males
D002264 Carboxylic Acids Organic compounds containing the carboxy group (-COOH). This group of compounds includes amino acids and fatty acids. Carboxylic acids can be saturated, unsaturated, or aromatic. Carboxylic Acid,Acid, Carboxylic,Acids, Carboxylic
D002839 Chromans Benzopyrans saturated in the 2 and 3 positions. Dihydrobenzopyrans
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Hiroo Koyama, and Julia K Boueres, and Daniel J Miller, and Joel P Berger, and Karen L MacNaul, and Pei-ran Wang, and Marc C Ippolito, and Samuel D Wright, and Arun K Agrawal, and David E Moller, and Soumya P Sahoo
August 2005, Journal of medicinal chemistry,
Hiroo Koyama, and Julia K Boueres, and Daniel J Miller, and Joel P Berger, and Karen L MacNaul, and Pei-ran Wang, and Marc C Ippolito, and Samuel D Wright, and Arun K Agrawal, and David E Moller, and Soumya P Sahoo
December 2006, Bioorganic & medicinal chemistry letters,
Hiroo Koyama, and Julia K Boueres, and Daniel J Miller, and Joel P Berger, and Karen L MacNaul, and Pei-ran Wang, and Marc C Ippolito, and Samuel D Wright, and Arun K Agrawal, and David E Moller, and Soumya P Sahoo
December 2006, Bioorganic & medicinal chemistry letters,
Hiroo Koyama, and Julia K Boueres, and Daniel J Miller, and Joel P Berger, and Karen L MacNaul, and Pei-ran Wang, and Marc C Ippolito, and Samuel D Wright, and Arun K Agrawal, and David E Moller, and Soumya P Sahoo
March 2008, Bioorganic & medicinal chemistry letters,
Hiroo Koyama, and Julia K Boueres, and Daniel J Miller, and Joel P Berger, and Karen L MacNaul, and Pei-ran Wang, and Marc C Ippolito, and Samuel D Wright, and Arun K Agrawal, and David E Moller, and Soumya P Sahoo
March 2008, Bioorganic & medicinal chemistry letters,
Hiroo Koyama, and Julia K Boueres, and Daniel J Miller, and Joel P Berger, and Karen L MacNaul, and Pei-ran Wang, and Marc C Ippolito, and Samuel D Wright, and Arun K Agrawal, and David E Moller, and Soumya P Sahoo
February 2002, Journal of medicinal chemistry,
Hiroo Koyama, and Julia K Boueres, and Daniel J Miller, and Joel P Berger, and Karen L MacNaul, and Pei-ran Wang, and Marc C Ippolito, and Samuel D Wright, and Arun K Agrawal, and David E Moller, and Soumya P Sahoo
May 2005, Current opinion in investigational drugs (London, England : 2000),
Hiroo Koyama, and Julia K Boueres, and Daniel J Miller, and Joel P Berger, and Karen L MacNaul, and Pei-ran Wang, and Marc C Ippolito, and Samuel D Wright, and Arun K Agrawal, and David E Moller, and Soumya P Sahoo
April 2007, Bioorganic & medicinal chemistry letters,
Hiroo Koyama, and Julia K Boueres, and Daniel J Miller, and Joel P Berger, and Karen L MacNaul, and Pei-ran Wang, and Marc C Ippolito, and Samuel D Wright, and Arun K Agrawal, and David E Moller, and Soumya P Sahoo
August 2009, Bioorganic & medicinal chemistry letters,
Hiroo Koyama, and Julia K Boueres, and Daniel J Miller, and Joel P Berger, and Karen L MacNaul, and Pei-ran Wang, and Marc C Ippolito, and Samuel D Wright, and Arun K Agrawal, and David E Moller, and Soumya P Sahoo
June 2008, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!